254 related articles for article (PubMed ID: 17080352)
1. [Can the determination of IgG antibodies to the pertussis toxin help the diagnosis of the disease?].
Holcíková A; Stroblová H; Jirsenská Z
Klin Mikrobiol Infekc Lek; 2006 Oct; 12(5):184-8. PubMed ID: 17080352
[TBL] [Abstract][Full Text] [Related]
2. Correlation between pertussis toxin IgG antibodies in postvaccination sera and subsequent protection against pertussis.
Taranger J; Trollfors B; Lagergård T; Sundh V; Bryla DA; Schneerson R; Robbins JB
J Infect Dis; 2000 Mar; 181(3):1010-3. PubMed ID: 10720524
[TBL] [Abstract][Full Text] [Related]
3. Differences in avidity of IgG antibodies to pertussis toxin after acellular pertussis booster vaccination and natural infection.
Barkoff AM; Gröndahl-Yli-Hannuksela K; Vuononvirta J; Mertsola J; Kallonen T; He Q
Vaccine; 2012 Nov; 30(48):6897-902. PubMed ID: 22981763
[TBL] [Abstract][Full Text] [Related]
4. IgG responses after booster vaccination with different pertussis vaccines in Dutch children 4 years of age: effect of vaccine antigen content.
Hendrikx LH; Berbers GA; Veenhoven RH; Sanders EA; Buisman AM
Vaccine; 2009 Nov; 27(47):6530-6. PubMed ID: 19729085
[TBL] [Abstract][Full Text] [Related]
5. Incidence of pertussis in persons < or =15 years of age in Valencia, Spain: seroprevalence of antibodies to pertussis toxin (PT) in children, adolescents and adults.
Diez-Domingo J; Ballester A; Baldó JM; Planelles MV; Villarroya JV; Alvarez T; Carmen Peidró M; Calero P; Garcés MD; Sorribes I; Graullera M; Jubert A; San-Martín M; González A
J Infect; 2004 Oct; 49(3):242-7. PubMed ID: 15337342
[TBL] [Abstract][Full Text] [Related]
6. Kinetics and sensitivity of ELISA IgG pertussis antitoxin after infection and vaccination with Bordetella pertussis in young children.
Hallander HO; Ljungman M; Storsaeter J; Gustafsson L
APMIS; 2009 Nov; 117(11):797-807. PubMed ID: 19845530
[TBL] [Abstract][Full Text] [Related]
7. Improved serodiagnosis of whooping cough caused by Bordetella pertussis by determination of IgG anti-LPF antibody levels.
Nagel J; de Graaf S; Schijf-Evers D
Dev Biol Stand; 1985; 61():325-30. PubMed ID: 2872120
[TBL] [Abstract][Full Text] [Related]
8. Assessment of IgA anti-PT and IgG anti-ACT reflex testing to improve Bordetella pertussis serodiagnosis in recently vaccinated subjects.
Subissi L; Rodeghiero C; Martini H; Litzroth A; Huygen K; Leroux-Roels G; Piérard D; Desombere I
Clin Microbiol Infect; 2020 May; 26(5):645.e1-645.e8. PubMed ID: 31610300
[TBL] [Abstract][Full Text] [Related]
9. Comparison of anti-pertussis toxin ELISA and agglutination assays to assess immune responses to pertussis.
Khramtsov P; Bochkova M; Timganova V; Zamorina S; Rayev M
Infect Dis (Lond); 2017 Aug; 49(8):594-600. PubMed ID: 28335677
[TBL] [Abstract][Full Text] [Related]
10. Should fimbriae be included in pertussis vaccines? Studies on ELISA IgG anti-Fim2/3 antibodies after vaccination and infection.
Hallander HO; Ljungman M; Jahnmatz M; Storsaeter J; Nilsson L; Gustafsson L
APMIS; 2009 Sep; 117(9):660-71. PubMed ID: 19703126
[TBL] [Abstract][Full Text] [Related]
11. Serum IgG antibody response to pertussis toxin in persons for whom pertussis vaccination failed depends upon the number of antigens in the vaccine.
Cherry JD
Clin Infect Dis; 1999 Mar; 28(3):560-1. PubMed ID: 10194078
[No Abstract] [Full Text] [Related]
12. Seroprevalence of IgG antibodies to pertussis toxin in the Slovene population.
Socan M; Prosenc K; Vegnuti M
Wien Klin Wochenschr; 2006 Jun; 118(11-12):336-40. PubMed ID: 16855922
[TBL] [Abstract][Full Text] [Related]
13. Immunogenicity of a single dose of reduced-antigen acellular pertussis vaccine in a non-vaccinated adolescent population.
Knuf M; Zepp F; Meyer C; Grzegowski E; Wolter J; Riffelmann M; Wirsing von König CH
Vaccine; 2006 Mar; 24(12):2043-8. PubMed ID: 16356597
[TBL] [Abstract][Full Text] [Related]
14. Modelling anti-pertussis toxin IgG antibody decay following primary and preschool vaccination with an acellular pertussis vaccine in UK subjects using a modified oral fluid assay.
Fry NK; Litt DJ; Duncan J; Vaghji L; Warrener L; Samuel D; Andrews N; Harnden A; Harrison TG
J Med Microbiol; 2013 Sep; 62(Pt 9):1281-1289. PubMed ID: 23722435
[TBL] [Abstract][Full Text] [Related]
15. The utility of seroepidemiology for tracking trends in pertussis infection.
Quinn HE; McIntyre PB; Backhouse JL; Gidding HF; Brotherton J; Gilbert GL
Epidemiol Infect; 2010 Mar; 138(3):426-33. PubMed ID: 19719902
[TBL] [Abstract][Full Text] [Related]
16. The seroepidemiology of Bordetella pertussis in Israel--Estimate of incidence of infection.
Rendi-Wagner P; Tobias J; Moerman L; Goren S; Bassal R; Green M; Cohen D
Vaccine; 2010 Apr; 28(19):3285-90. PubMed ID: 20226250
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of a tetraplex microsphere assay for Bordetella pertussis antibodies.
Prince HE; Lapé-Nixon M; Matud J
Clin Vaccine Immunol; 2006 Feb; 13(2):266-70. PubMed ID: 16467336
[TBL] [Abstract][Full Text] [Related]
18. Seroprevalence of Bordetella pertussis infection during pregnancy measured by IgG antibodies against pertussis toxin.
Nooitgedagt JE; de Greeff SC; Elvers BH; de Melker HE; Notermans DW; van Huisseling H; Versteegh FG
Clin Infect Dis; 2009 Oct; 49(7):1086-9. PubMed ID: 19725791
[TBL] [Abstract][Full Text] [Related]
19. Age-related differences in antibody avidities to pertussis toxin and filamentous hemagglutinin in a healthy Japanese population.
Fumimoto R; Otsuka N; Sunagawa T; Tanaka-Taya K; Kamiya H; Kamachi K
Vaccine; 2019 Apr; 37(18):2463-2469. PubMed ID: 30930008
[TBL] [Abstract][Full Text] [Related]
20. Antibody responses to pertussis toxin display different kinetics after clinical Bordetella pertussis infection than after vaccination with an acellular pertussis vaccine.
Dalby T; Petersen JW; Harboe ZB; Krogfelt KA
J Med Microbiol; 2010 Sep; 59(Pt 9):1029-1036. PubMed ID: 20508003
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
